Gensia Inc., Genta deal

The Geomatrix controlled-release formulation of the drug was developed by Genta Jago, a joint venture between GNTA (San Diego) and Jagotec AG.

Read the full 225 word article

How to gain access

Continue reading with a
two-week free trial.